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become lost to follow up from an antiretroviral
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Beth Rachlis1, Farah Ahmad1,2, Monique van Lettow1,3*, Adamson S Muula4, Medson Semba5 and Donald C Cole1Abstract
Background: Retention in antiretroviral therapy (ART) programmes remains a challenge in many settings including
Malawi, in part due to high numbers of losses to follow-up. Concept Mapping (CM), a mix-method participatory
approach, was used to explore why patients on ART are lost to follow-up (LTFU) by identifying: 1) factors that
influence patient losses to follow-up and 2) barriers to effective and efficient tracing in Zomba, Malawi.
Methods: CM sessions (brainstorming, sorting and rating, interpretation) were conducted in urban and rural
settings in Zomba, Malawi. Participants included ART patients, ART providers, Health Surveillance Assistants, and
health managers from the Zomba District Health Office. In brainstorming, participants generated statements in
response to “A specific reason why an individual on ART becomes lost to follow-up is…” Participants then sorted
and rated the consolidated list of brainstormed items. Analysis included inductive qualitative methods for grouping
of data and quantitative cluster identification to produce visual maps which were then interpreted by participants.
Results: In total, 90 individuals brainstormed 371 statements, 64 consolidated statements were sorted (participant
n = 46), and rated on importance and feasibility (participant n = 69). A nine-cluster concept map was generated and
included both patient- and healthcare-related clusters such as: Stigma and Fears, Beliefs, Acceptance and Knowledge
of ART, Access to ART, Poor Documentation, Social and Financial Support Issues, Health Worker Attitudes, Resources
Needed for Effective Tracing, and Health Worker Issues Related to Tracing. Strategies to respond to the clusters were
generated in Interpretation.
Conclusions: Multiple patient- and healthcare focused factors influence why patients become LTFU. Findings have
implications particularly for programs with limited resources struggling with the retention of ART patients.
Keywords: Concept mapping, HIV/AIDS, Antiretroviral therapy (ART), Losses to follow-up, MalawiBackground
Globally, 34 million people were living with HIV/AIDS
by December 2010 and the majority resided in sub-
Saharan Africa [1]. In Malawi, the prevalence of HIV is
estimated as 11% [2,3] and over 650,000 children have
been orphaned by AIDS [4]. By June 2010, approxi-
mately 58% of those in need were receiving antiretroviral
therapy (ART) [5] although disparities continue to exist
in access to treatment options, particularly for individ-
uals living in rural areas [6].* Correspondence: m.vanlettow@dignitasinternational.org
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reproduction in any medium, provided the orLosses to follow-up (LTFU) from antiretroviral therapy
is a major cause of patient attrition [7]. LTFU can be
considered a catch-all category for patients who miss
scheduled appointments or medication pick-ups (over a
period of time) although operational definitions vary [8].
In Malawi, the term ‘LTFU from ART’ refers to a patient
who is overdue for their appointment and is not known
to have stopped ART, died, or transferred to another
facility [9]. Importantly, patients who discontinue treat-
ment are vulnerable to drug resistance, AIDS-related ill-
nesses, and death [7,8,10-12].
While various reasons are known, demonstrating asso-
ciations between various variables and risk of becoming
LTFU remains challenging. Reported reasons for LTFULtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[13-15], financial constraints [14,16,17], religious and
family influences [14,16,18,19], wanting to access trad-
itional medicine [20], stigma and fear of disclosure of
HIV status [10,19-22], living far from clinics and trans-
port-related costs [10,14,18,20,23], and poor patient-
provider relationships [10,14,20]. Treatment literacy
(e.g., understanding the natural course of treatment and
the need for adherence to ART) [24,25], experiencing an
improvement in health and believing that treatment is
no longer necessary [10] may also matter. Some of these
are consistent with the findings of our 2011 systematic
review exploring livelihood factors and ART adherence
[25] although we were limited by the available literature
and could not identify new factors that may be relevant
or specific to Malawi. Furthermore, our understanding
of how these various factors potentially interact to influ-
ence whether a patient becomes LTFU over time, re-
mains rudimentary [21].
Zomba is one of Malawi’s most populated districts
(population: 670,500) and is predominantly rural [26].
Within Zomba, HIV prevalence is 14.5% although esti-
mates have varied by location and population group,
ranging from 12% in an urban centre to >30% at a rural
hospital [27,28]. In collaboration with the Malawi Minis-
try of Health, Dignitas International (DI), a humanitarian
non-governmental organization, has delivered compre-
hensive HIV/AIDS care in Zomba since 2004, enrolling
over 20,000 patients on ART. The decentralization of
services to rural areas has led to a rapid increase in the
number of people accessing ART in the district.
In order to improve patient retention in DI’s ART pro-
gram, we sought to comprehensively identify factors that
influence why patients become LTFU as well as factors
that impede successful tracing efforts.
Methods
Concept Mapping (CM) is a participatory mixed-
methods approach that enables diverse groups of stake-
holders to share their ideas, representing them in various
quantitatively derived visual concept maps [29,30]. CM
has three phases: brainstorming of statements in re-
sponse to a focus prompt; sorting and rating of the
consolidated list of brainstormed statements; and inter-
pretation where participants discuss and interpret the
maps identifying priority areas for action. The use of
CM in this context was advantageous as our aim was to
identify the most important and feasible interventions/
strategies that address patient retention [31].
Sample
To ensure a variety of viewpoints, purposive sampling
was used to include a heterogeneous participant popula-
tion with respect to patient losses to follow-up. Partici-pants were selected based on their previous experience
with ART and included patient and provider groups. Pa-
tient participants included patients who had become
LTFU while on ART as well as expert patients (patients
on ART trained to assist with clinical tasks and counsel-
ling). Provider participants consisted of ART providers
(clinical officers, medical assistants, and nurses), Health
Surveillance Assistants (HSAs) involved with patient
tracing, and members of the Zomba District Health
Office (DHO) health management team involved in ART
provision. We sought a balanced mix of participants
working or receiving care either at Zomba Central
Hospital (centralized) or in one of three decentralized
rural clinics that varied in terms of distance to Zomba
town and patient volume (small versus large). Separate
sessions were held for patient and provider groups to
avoid responder bias (e.g., patients may not speak freely
or may provide responses they think providers want to
hear). The brainstorming and rating sessions were ar-
ranged with a larger number of diverse participants to
capture heterogeneity whereas sorting and rating
sessions were conducted with smaller and more alike
participants for homogeneity [32]. Sessions were con-
ducted in English (provider groups) or Chichewa (pa-
tient groups). Inclusion criteria included being at least
18 years of age and having experience with ART as a
patient, provider, manager, or through tracing. An
additional criterion of having at least a secondary school
education was applied for sorting which required read-
ing and comprehension skills. All CM activities took
place in May-July 2011. All CM activities were facilitated
by an experienced Malawian research assistant who was
briefly trained in CM methodology and was fluent in
both English and Chichewa.
Recruitment
In collaboration with local partners at DI, the University
of Malawi, and the DHO, the research team and a bilin-
gual research assistant distributed a study information
sheet (SIS) to potential participants. To reach provider
participants, the SIS was distributed to staff at participat-
ing clinics and the DHO. To reach the patient popula-
tion, collaborating providers disseminated the study
information to their patients. Interested individuals
contacted the research team for further details. Patients
who were currently LTFU (i.e. had not been seen in
care) were identified through a master list of currently-
missing patients, generated by DI (and shared with the
DHO). Those patients who were identified as LFTU
were then contacted (via phone or in person during
tracing with HSAs) and if successfully found, were
invited to participate in the study. Willing partici-
pants provided informed written consent. Participants
recruited in brainstorming were invited to participate in
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pretation. To allow flexibility to participate, both group
sessions and one-on-one sessions were conducted for all
phases although generally brainstorming and interpret-
ation was done in group sessions to generate discussion.
Sessions were conducted in private rooms at participat-
ing clinics and at the DHO. At the time of recruitment,
all patients were informed that by participating in group
sessions, they were disclosing their HIV positive status
to the other members attending the session. Further-
more, participants were informed that any concerns or
issues they had before, during (any phase), or after the
study would be addressed confidentially by the study
team as outlined in the SIS and consent form. Snacks
were provided and all patient participants received a
1 kg bag of sugar or a chitenje (local fabric) and 200
Malawian Kwacha (approximately $1.20 Canadian at the
time of the study) to help cover travel costs. Ethical ap-
proval was obtained from the University of Toronto HIV
Research Ethics Board and the National Health Sciences
Research Committee in Malawi.
Brainstorming
Our focus prompt was developed in consultation with
DI and pilot-tested with patients at Zomba Central
Hospital. Participants were prompted to generate state-
ments in response to “Why do individuals on ART be-
come lost to follow-up over time?” To help participants
understand ‘lost to follow-up’, several descriptions were
provided including when patients: stop taking their ART,
stop coming for appointments, or can’t be found by
health providers. Each statement generated in brain-
storming was captured by the facilitator. Overall, 90 par-
ticipants (ten group sessions; five individual sessions)
generated 371 statements.
Once all sessions were completed, statement consoli-
dation was initiated. Statements in Chichewa were first
translated into English. Each statement generated was
read aloud in sequence with the focus prompt (i.e., A
specific reason why an individual on ART becomes lost
to follow-up is… statement generated in brainstorming).
Statements that did not answer the prompt were consid-
ered irrelevant and were removed. The remaining state-
ments were organized into broad themes (e.g., tracing
issues), duplicates eliminated, and similar statements
merged to create a final consolidated list. The refined list
of 64 statements was then back-translated into Chichewa
for sorting and rating. Translations were verified by a
bilingual DI staff member.
Sorting and rating
Sorting activity was completed individually by 46 partici-
pants (six group sessions; eight individual sessions).
Each participant received a deck of 64 cards with onestatement per card. Participants were instructed to make
piles of similar statements in ways that made sense to
them and to give labels to each pile they created to
reflect the statements within. Prior to each session, the
facilitator provided an example based on food (e.g.
crunchy, soft, sweet, and sour) to explain how different
people may sort the same item in different ways. Rating
was completed by 69 participants (six group sessions;
twenty-three individual sessions). Participants rated each
statement using a Likert 5-point scale, along two
dimensions:
Importance: (i.e., how important the statement is with
respect to why patients become lost to follow-up)
(1- not at all important to 5- extremely important,
compared to all other statements);
Feasibility: (i.e., how feasible it would be to address this
statement in order to prevent patients on ART from
becoming lost to follow-up) (1- not at all feasible to 5-
extremely feasible, compared to all other statements).Analysis and generation of maps
Upon completion of the sorting and rating activities,
data were exported into Concept Systems Software
(Concept System Program, Concept Mapping Incorpo-
rated, 2005) to create a final cluster solution prior to the
interpretation session. Using the statistical technique of
a similarity index, the program first determined the
number of participants who sorted each pair of state-
ments together. Each statement was then located in
relation to all others on a two-dimensional point map
(statements sorted together frequently were located close
together). Next, a cluster concept map was generated
from the point map to show how the statements could
be organized into clusters with common themes using
hierarchical cluster analysis [29]. In this step, the re-
searchers examined several cluster maps by forcing an
upper and lower limit to the number of clusters in a
map. The team began with the upper limit of 15 clusters
and merged one cluster at a time until the lower limit of
5 clusters was reached. They examined changes in the
cluster solution at each merging step. The final cluster
map was identified through consensus among re-
searchers on the number of clusters that retained the
most meaningful detail between clusters. Clusters that
are smaller in size indicate that statements that make up
the cluster were more similarly grouped by participants
during sorting relative to larger sized clusters. A stress
value statistic reflecting a goodness-of-fit of the point
map to the similarity matrix was calculated. Generally,
indices range from 0.15 to 0.35 [29,33]. In the present
study, the stress value was 0.28 indicating an acceptable
value. Bridge maps were generated to explore the
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and across provider and patient groups.Interpretation of maps
Overall, 35 participants interpreted the maps (five group
sessions; 3 individual sessions) documenting key findings
with the facilitator. Participants discussed the content of
the main clusters and reached agreement through consen-
sus on the most appropriate cluster labels out of the sev-
eral labels generated individually by participants during
the sorting activity. Through the examination and com-
parison of the “Importance” and “Rating” variables for
each cluster, the most actionable clusters were identified
(e.g. where efforts to address LTFU should be directed).
Clusters with a rating value of ≥3 are discussed in detail.Results
Participants
Participant characteristics are presented in Table 1.
Fifty-four percent were women and 49% were under the
age of 35 (median: 32, IQR: 27–38). An overview of the
CM methods and the number of participants in each
stage is presented in Figure 1.Cluster solution
A nine cluster concept map was generated (Figure 2).
Clusters included: Stigma and Fears (8 statements);
Beliefs (5 statements); Lack of Knowledge and Acceptance
(11 statements); Access to ART (5 statements); Poor
Documentation (5 statements); Social and Financial
Support Issues (8 statements); Health Worker Attitudes
(8 statements); Resources Needed for Effective Tracing
(6 statements); and Health Worker Issues Related to Tra-
cing (8 statements). The map was further divided into
two cognitive regions: upper region clusters generally
focused on patient-related factors whereas lower region
clusters were more healthcare-focused.Table 1 Number of participants in brainstorming, sorting, rat
Groups













Note: Provider participants included ART providers, Zomba District Health Office Ma
to follow-up.Rating and bridge map
Table 2 presents the mean cluster ratings with associated
standard deviations. Table 3 presents all statements. For
the rating of “importance” of items, the clusters with the
highest rating values were Poor Documentation, Resources
Needed for Effective Tracing, and Social and Financial
Support Issues. For the rating of “feasibility” of items to ad-
dress, the clusters with the highest rating values were Re-
sources Needed for Effective Tracing, Poor Documentation,
and Health Worker Issues Related to Tracing. Generally,
ratings were higher for “feasibility” although agreement
between the rating variables at the cluster level was rela-
tively high. Patient and providers both gave higher rating
values to clusters in the healthcare-related region versus
the patient-related region with the exception of Social and
Financial Support Issues. Provider groups rated clusters in
the healthcare-related region as more feasible to address
although this pattern was less clear for patient groups
(data not shown).
Participant interpretation
Clusters in the healthcare-related region
In relation to Poor Documentation, provider participants
noted that the date and outcomes (e.g., health status,
ART supply given) of patient visits are often not
recorded accurately, if at all. This was attributed to a
high volume of patients, a shortage of health staff, and a
lack of proper filing space. ART providers further real-
ized that while patients may be given their ART, if the
visit was not recorded, the patient may be incorrectly la-
belled as LTFU. Participants noted that some patients
provide false contact information to hide from follow-
up. Without an accurate address, patients can’t be found
and remain LTFU. While improving documentation was
rated a feasible issue to address, participants struggled to
come up with potential strategies that could be used to
address documentation issues.
With respect to the clusters on Tracing, transportation
challenges emerged. While HSAs mostly walk or use aing, and interpretation activities
# Participants
Rural area (Pirimiti, Mayaka, Chingale) Total
23 (including n=9 LTFU) 41
20 49
9 (including n = 1 LTFU) 20
12 26
20 (including n = 2 LTFU) 34
18 35
20 patients (including n = 1 LTFU) 20
15 15
nagement Team, and Health Surveillance Assistants; LTFU = patient lost
Consolidation of 371 statements
Brainstorming 
(n=90)
Sorting (n=46) and 




Multidimensional scaling & 
Hierarchical cluster analysis
Figure 1 Overview of the concept mapping process.
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roads. Some HSAs noted that they do not even live in
their catchment areas and so have to travel far to get to
areas where they then can start tracing. Interestingly,
this was contested by DHO participants who mentioned
that HSAs should be living in their catchment areas. A
lack of housing options or the need to move with family
may help to partially explain this finding. Timing of tra-
cing was also discussed and according to one ART pro-
vider: “by waiting more than 2 months to start tracing, a
patient is already lost.” Provider participants suggested
that tracing should be initiated earlier and patients
should be prioritized for tracing. A master list of pa-
tients expecting to be seen each week could be gener-
ated at each clinic. When a patient doesn’t show up,
participants felt that tracing should begin immediately.
ART providers suggested that lessons could be drawn
from successes with Tuberculosis (TB) tracing.
In relation to Health Worker Attitudes patients noted
that providers often use exposing language (e.g., ‘ARTStigma and Fears
Beliefs






Figure 2 Final nine cluster concept map.patients in this line’). Participants generally agreed that
enhanced one-on-one counselling could help improve a
patient’s overall knowledge of the importance of adher-
ence as well as help to manage fears and expectations.
Clusters in the patient-related region
Social and Financial Support Issues were also discussed.
Many patients referred to strict hospital policies includ-
ing the need to come to care with a guardian (e.g., family
member) as a reason why patients may miss scheduled
visits. This would be particularly problematic for pa-
tients who have not disclosed their HIV status or who
lack a guardian. Interestingly, providers in our study
noted that this specific policy was no longer in effect.
Being too sick to come to the clinic was the most im-
portant and feasible statement to address (data not
shown). HSAs spoke to experiences where they traced
patients that had been too sick to make it to their ap-
pointments. To minimize the likelihood that patients
(particularly those without guardians) stop taking ART,Lack of Acceptance 





Health Worker Issues 
Related to Tracing
Table 2 Cluster characteristics and ratings
Cluster Importance rating Feasibility rating
Mean (SD) Mean (SD)
Poor documentation 3.3 (0.18) 3.5 (0.31)
Resources needed for
effective tracing
3.3 (0.23) 3.6 (0.14)
Social and financial
support issues
3.3 (0.35) 3.4 (0.34)
Health worker attitudes 3.1 (0.25) 3.5 (0.27)
Health worker issues
related to tracing
3.1 (0.40) 3.5 (0.20)
Stigma and fears 2.9 (0.44) 3.4 (0.29)
Access to ART 2.7 (0.23) 3.1 (0.22)
Beliefs 2.6 (0.35) 3.0 (0.17)
Lack of knowledge
and acceptance
2.6 (0.52) 2.9 (0.33)
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to the patients in their homes. Patients suggested that
there could be a phone number that they can call if they
are too sick to come for care. As elaborated by one pa-
tient, the hospital can then make alternate arrangements
for them (e.g., providing transport). Some patients re-
ferred to a lack of food needed to take with ART as a
reason why patients may become LTFU. However, other
patients suggested that even if food supplement were
provided at the clinics, individuals may choose to not
come given that others would know where they got their
food from and identify them as HIV positive.
Finally, participants discussed the need for education
for church leaders as often it is church leaders who dis-
courage patients from taking ART. Having a chaplain at
the hospital to provide social and religious support was
also suggested as a way to encourage ART adherence
and prevent losses to follow-up.
Discussion
In the present study, we used CM to incorporate both pa-
tient and provider perspectives to comprehensively and
systematically identify important and feasible issues to ad-
dress with respect to why patients on ART become LTFU
over time. The final 9 cluster concept map consisted of
both patient- and healthcare-related clusters. The findings
of the present study can inform the development of strat-
egies that work to prevent patients from becoming LTFU
including improved tracing efforts.
Poor Documentation and Resources Needed for Effect-
ive Tracing were rated important and feasible clusters to
address. Importantly, the quality and accuracy of data
(including data on patients who become LTFU) can vary
across large longitudinal cohort studies [34,35]. While
reliable ART monitoring is critical for measuring patient
outcomes and program performance [35,36], data mana-gement can be particularly challenging in resource-poor
settings [34,35,37-39]. This has been attributed to poor
infrastructure, a lack of trained personnel, and clinic
characteristics including patient volume [35,38]. Often
front line health workers involved in data collection lack
a clear understanding as to how the data they collect will
be used and how particularly, it is relevant for their day-
to-day activities [34,40]. Improving quality data collection,
however, may require incentives and ongoing training
and supervision for personnel [35,38,40], specifically
because data collection can be burdensome [35,37].
Programs with electronic monitoring systems have
demonstrated better quality data [35,36] and it is worth
noting that DI has improved their electronic system
since 2007 although challenges remain. Indeed, ART pro-
viders in our study spoke to limited storage space as one
reason why files become misplaced and/or lost. Import-
antly, our findings suggest that while there are patients
who truly become LTFU, poor documentation may lead
some patients to be incorrectly labelled as LTFU (e.g., the
files were lost, visit was not recorded). For example, miss-
ing patients may have also transferred to another clinic
and therefore may only be LTFU from the perspective of
their original clinic [35]. Therefore, identifying where (e.g.,
which clinics) and when (e.g., data entry, filing) errors
occur is a necessary first step in order to determine how
it can be addressed although enhanced documentation,
improved coordination between clinics (when there are
transfers), and effective tracing of missing patients are all
necessary components [7,41].
Tracing clusters were identified as important and feas-
ible to address in the present study. Participants noted
that, based on current definitions and guidelines, tracing
may be initiated too late in Malawi. Some studies have
suggested that patient retention can be improved when
tracing is initiated as soon as possible (dependent on
available resources) as this can minimize the likelihood
that patients remain LTFU [17,42]. Prioritizing who gets
traced and when could mean that fewer patients need to
be traced as many patients may ultimately return on
their own. Prioritization can be determined through the
identification of particular clinical markers that are asso-
ciated with an increased likelihood of becoming lost or
an increased risk of death. In Malawi, for example, risk
of death is highest in patients who have recently initiated
ART. This suggests that time on ART may be an import-
ant way to prioritize patients for tracing [41].
Drawing from the experiences of TB programs, tracers
specific to ART could be trained [43] although important
differences in the management and perceptions of HIV
are important considerations. For example, the largely
sexual transmission and labelling of HIV as a ‘moral dis-
ease’ makes anonymity and confidentiality of those living
with HIV extremely important [22]. Home visits by
Table 3 The consolidated list of 64 statements
Cluster Statements
Poor documentation Poor filing means that patient files can get lost when patients on ART are being transferred
The patient has died but their death is not reported
Patients have little social support in the villages due to lack of counsellors,
support groups and community-based organizations
The patient has moved away to another clinic without being properly transferred
Patient visits are not being recorded accurately
Resources needed for
effective tracing
Tracing starts too late because of the way a ‘defaulter’ is defined
(e.g., missing an appointment by 2 months or more)
The HSAs have difficulty locating patients because they do not live in
their catchment areas and therefore do not know the villages where people come from
Patients on ART can’t be found if the HSAs do not have their proper address and/or their locator forms
They live in areas that are difficult to reach so that the HSAs have difficulty tracing them
Health workers have difficulty locating patients without working phones or phone numbers
There is no fuel or dedicated transport for tracing
Social and financial support issues Being too sick to come to the clinic
The distance to the clinic is too far from some patients on ART
The guardians of the patient refuse to go the hospital to collect their ARVs from them
Patients on ART can’t afford transport means to come to the clinic because they face poverty
A lack of support for ART patients especially when they are orphans
Patients on ARV medicines may also have to deal with other diseases such as chronic illness
Patients on ARV medicines feel hungry but they can’t afford to buy extra food
They are attending to another sick relative (e.g., child)
Health worker attitudes Patients are on ART feel that there is a lack of confidentiality on behalf of
the health workers (e.g., drugs given without privacy)
Patients on ART get disappointed when they are not put on a different
ART regimen to help manage their side effects
Patients are not properly educated on ART because of little one-on-one counselling with the health workers
Patients on ART do not like the way they are treated by health workers
Patients feel shy to come to the health centre because there is limited space and no privacy
Patients on ART get frustrated because it takes too long before they are seen at the hospital
Anxiety about going back to the clinic after missing many appointments
To hide from follow-up, patients change their names and identities
Health worker issues related to tracing There are too many patients needing to be traced and not enough health workers to trace them
Poor communication and coordination between the HSA and ART providers
There is no coordinator for ART tracing and no specific follow-up health workers
There is no training on how to do the follow-up of ART patients
The health workers just wait for the patients to come back on their own
because their are no consequences for them if they don’t trace them
There is no deliberate effort to trace ART patients because there are no incentives for the HSAs
The HSAs do not actually trace patients and instead write fake information about patient visits
The HSAs don’t value tracing because they have too much other work
Stigma and fears The patient on ART fears stigmatization because they are transferred to a
health centre that is near to where they live
Fear of divorce if their spouse or loved one discover that they are on ART
The patient doesn’t want to be associated with ARV drugs because of stigma and fear of isolation
Patients on ART experience side effects from the medicine
Patients on ART fear side effects and the unknown
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Table 3 The consolidated list of 64 statements (Continued)
Patients on ART face mental health issues
Patients stop coming to the clinic because they get their ARV drugs from somewhere else
Fear dismissal at the work place because their employer may discover that they are on ART
Access to ART Patients have difficulty finding ARVs when they travel both within and outside the country
ARV medicines are not always accessible because of inconsistent drug availability
Not being able to meet strict hospital policies (e.g., coming with a guardian)
The patient just picked up a guardian at the market and the guardian cannot be used to trace the patient
Patients are mobile and they move around a lot
Beliefs Religion and the belief that prayer, not ARVs, will heal them
Church fellowships discourage them from taking their ARVs and tell them they are healed from HIV
Patients on ART believe that they are HIV negative because they gave birth
to a negative baby or re-tested negative for HIV
Beliefs in traditional medicines
Patients on ART believe that they are healed from HIV if they sleep with a virgin or a younger person
Lack of knowledge
and acceptance
Patients feel tired of taking their drugs
Patients on ART don’t see the need to be on drugs anymore when
they feel better and their health has improved
When there is no improvement in their health, patients on ART are
frustrated because they were expecting a quick recovery
The patient on ART has not accepted their HIV status
Patients on ART want to have a normal life and feel the medicine is a burden
Patients on ART are just not serious about their lives
Patients see no value in taking their ARVs anymore because they have given up on life
Patients find new marriage partners and do not want them to find out that they are on ART
Pregnancy and wanting to protect the unborn child from ART
Patients prefer alcohol over taking ART
Patients have too many lovers and not enough time to take their ARVs
ARV antiretroviral, HSA Health Surveillance Assistant.
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status [21]. These factors have important implications
for how ART tracing efforts should be implemented
although as participants in the present study, as well as
elsewhere [35,41] have noted, accurate contact informa-
tion is needed to ensure that patients can actually be
found. While the number of patients with cell phones is
growing (by 2008, approximately 15% of Malawians were
reportedly using cell phones), many patients, particularly
those in remote settings, continue to be without working
phones [44]. Importantly, while a working phone num-
ber is one of the strongest predictors of successfully
finding patients [41,45] many still do not return to care
[40,42,46,47]. With enhanced training on ART counsel-
ling, HSAs may be better equipped to encourage the
patients they trace to return to care. Currently, many
struggle with questions from patients related to the need
for adherence and/or management of side effects.
Participants rated Social and Financial Support Issues
high on importance. Poor health and feeling sick havebeen previously associated with stopping ART and/or an
increased risk of becoming LTFU [10,48,49]. During
interpretation, participants determined that HSAs and
guardians can help support patients who are unwell by
bringing ART to patients in their homes when they are
too sick to travel [50]. The identification of the potentially
important role of guardians was, to our knowledge, a find-
ing unique to our study. Disclosure of one’s HIV status has
been recognized as a double-edged sword [51] - having
the potential to yield needed social support but that
may also result in stigmatization and abandonment
[51-53]. Through participation in support groups, pa-
tients have a safe place to share experiences and support
one another which can also strongly motivate patients
to adhere to ART [22].
Findings around transport-related costs are consistent
with previous studies [10,14,17,18,20]. Patients often
have to choose between using their limited income on
transport or food for themselves/families [54]. Indeed
food insecurity and the perception that ART needs to be
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patients can make it to their visits and keep taking their
meds [13-15,55,56]. While providing food supplements
at the clinics may encourage patients to remain in care
[15], this may also deter others, particularly when indi-
viduals do not want to be associated with ART. Future
research is needed to identify strategies that improve pa-
tient retention while supporting patients with logistical
challenges that may place them at increased risk for be-
coming LTFU.
A brief discussion on Health Worker Attitudes and
Stigma and Fears is warranted given rating values. It is
worth noting that these clusters included both patient-
and healthcare- related statements. Within Health Worker
Attitudes for example, statements largely speak to pa-
tient frustrations with the healthcare they receive
particularly around the use of exposing language [21].
Stigma has been previously associated with patients
stopping treatment in Malawi [10]. While taking ART
can provide patients with a renewed sense of life,
allowing them to get back to work and take care of their
families, stigma continues to play a powerful role [22].
Experiences of HIV-related stigma can not only affect
adherence to ART but may also impact on social aspira-
tions and trajectories linked to a positive identity [21].
While we were surprised that Stigma and Fears was not
rated higher, participants in the present study may view
stigma as an underlying issue rather than a more imme-
diate cause of why patients become LTFU. For example,
a patient may seek care further from his/her home for
fear of stigmatization, resulting in having a farther dis-
tance to travel, thereby increasing transport costs. The
latter issue may be seen to be the more immediate issue
and as a result, given a higher rating value. In fact, in a
recent study, transport costs and other logistical bar-
riers were more commonly reported reasons for why
patients become lost when compared to stigma [49].
Healthcare delivery models that acknowledge patient
fears related to stigmatization and isolation are critical
as these can undermine relationships that are essential
for survival [57,58].
There were several limitations in our study. Firstly,
while we attempted to include the perspectives of several
stakeholder groups, numerous potentially relevant stake-
holders with important perspectives may not have been
adequately represented including family members of
ART patients and religious leaders. Excluding partici-
pants without a secondary school education from
sorting activities may have biased our final cluster
map towards a more highly educated population al-
though it is worth noting that a secondary school
education was not required for the other study
phases. While sampling was purposive, due in part
to feasibility issues, more providers than patientsparticipated in sorting and rating which may further
bias our findings more towards a provider perspec-
tive. Participant fatigue/sorting burden may have been
particularly important during sorting although we
attempted to limit the number of statements to be
sorted. Rating may have also been impacted by par-
ticipant fatigue which may help to explain the small
range of rating values. Social desirability bias may be
present in interpretation activities where participants
were asked to interpret results in which many applied
to shortfalls in healthcare although participants were
informed at the start of the study that all perspectives
were valuable. Individuals who chose to volunteer and
participate in this study may have been fundamentally
different from those who declined to participate, par-
ticularly if they have had poor experiences in the past
with researchers or their service providers in general.
Related to this is the recruitment of patients who
were already LTFU. Those that were reachable by
phone or in person and agreed to participate may be
different from those we could not find. Regardless,
differences in participation across individuals we
attempted to recruit may impact on the genera-
lizability of our findings to the broader population of
interest (e.g., ART patients in Zomba). Finally, while
our findings may not be generalizable to individuals
outside of Malawi, the concept map presented here
identified linkages between various factors that
influence losses to follow-up and therefore, may
be of interest to ART managers and providers
internationally.
Conclusions
Through the incorporation of patient (including those
who were LTFU), provider, and decision-maker per-
spectives, we determined that individuals can become
LTFU for a multitude of patient- and healthcare-
related reasons. In general, nine major themes related
to why individuals become LTFU emerged and were
identified. Poor documentation and issues related to
tracing were identified as being particularly important
in our context. CM offered a unique approach that
combined the strengths of qualitative methodologies
of data collection with quantitative methods of ana-
lysis to further our understanding of LTFU in ART
programs in the Malawian setting. Both patient and
provider perspectives were brought to the forefront,
and offered insight into potential priority areas for
action. Findings of the present study have implica-
tions for strategies that maximize patient retention in
ART programs including improved documentation of
patient visits, enhanced coordination between clinics
involved in transfers, and more comprehensive coun-
selling for patients.
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